Clinical Trials
| Cancer Type: Colon | |
| Description: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer |
|
| Entity Approving The Trial: North Central Cancer Treatment Group (NCCTG) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 2,300 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| No related links found. |
 |
 |
|
